BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 24, 2005
View Archived Issues
CytoGenix launches vaccine program using cell-free synthetic DNA production
Read More
Aegis and Albany Medical College to develop antiobesity nasal spray
Read More
Bayer and Asklepios enter hemophilia gene therapy alliance
Read More
Antibodies designated by PDL as lead candidates for cancer therapy
Read More
Viragen discontinues development of IEP 11 peptide
Read More
ExonHit Therapeutics and Allergan extend strategic alliance
Read More
Lilly receives additional E.U. approvals for Strattera
Read More
Positive safety profile for DelSite's intranasal vaccine delivery system
Read More
Valentis gains rights to Del-1 antibody
Read More
Sirtris completes licensing agreement for Washington U HDAC intellectual property
Read More
Bionaut Pharmaceuticals and NCI enter cancer research collaboration
Read More
Chiron and Enanta agree to develop and commercialize HCV protease inhibitors
Read More
AS-6 activates sGC and induces hypotensive effects in rats
Read More
Novel positive modulator of alpha7 nAChR described
Read More
Solabegron hydrochloride induces bladder relaxation and improves bladder storage mechanism in vivo
Read More
Chinese scientists develop and test a novel AT1 receptor antagonist
Read More
Novel carbapenems with broad antibacterial activity developed
Read More
Sustained-release Melanotan shows promise in preclinical and clinical studies
Read More
Clinical evidence of the benefits of bevacizumab in patients with eye disorders
Read More
Update on motexafin gadolinium in the treatment of solid tumors
Read More
Final phase I results of LEP-ETU in advanced cancer
Read More
Myogen evaluates ambrisentan in PAH patients refractory to other ERA therapies
Read More
First data on the effects and safety of S-CKD-602 in patients with advanced solid tumors
Read More
Nemifitide reported safe and effective for major depression
Read More
Eisai receives approval for Aricept Evess orodispersible tablets in U.K.
Read More
Fontolizumab reduces Crohn's disease activity in an open-label study
Read More
STA-5326 shows potential for Crohn's disease
Read More
Novel therapeutics for cardiovascular diseases reported in recent patents
Read More
L-000845704: an alphavbeta3 integrin antagonist in trials for osteoporosis
Read More
New therapeutics for cancer disclosed in recent patents
Read More